Trends in seroprevalence of human papillomavirus type 16 among pregnant women in Stockholm, Sweden, during 1969-1989

International Journal of Cancer

Volumn 76, Issue 3, 1998, Pages 341-344

  Af Geijersstam, Veronika ^a   Wang, Zhaohui ^a   Lewensohn Fuchs, Ilona ^b   Eklund, Carina ^a   Schiller, John T ^c   Forsgren, Marianne ^b   Dillner, Joakim ^a,d  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c NATIONAL CANCER INSTITUTE   (United States)

^d NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HERPES SIMPLEX VIRUS 2; HUMAN; INFECTION RATE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SEROPREVALENCE; SEXUALLY TRANSMITTED DISEASE; SWEDEN; UTERINE CERVIX CANCER; WART VIRUS;

EID: 0031800393     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980504)76:3<341::AID-IJC10>3.0.CO;2-E     Document Type: Article

References (36)

1. ANDERSSON-ELLSTRÖM A., DILLNER, J., HAGMAR, B., SCHILLER, J. and FORSSMAN, L., No serological evidence for non-sexual spread of HPV 16. Lancet, 344, 1435 (1994).
2. ANDERSSON-ELLSTRÖM, A., DILLNER, J., HAGMAR, B., SCHILLER, J., SAPP, M., FORSSMAN, L. and MILSOM, I., Comparison of development of serum antibodies to HPV 16 and HPV33 and acquisition of cervical HPV DNA among sexually experienced and virginal young girls. A longitudinal cohort study. Sex. Transm. Dis., 23, 234-238 (1996).
3. CARTER, J.J., KOUTSKY, L.A., WIPF, G.C., CHRISTENSEN, N.D., LEE, S.K., KUYPERS, J., KIVIAT, N. and GALLOWAY, D.A., The natural history of human papillomavirus type 16 capsid antibodies among a cohort of university women. J. Infect, Dis., 174, 927-936 (1996).
4. CHIEF MEDICAL OFFICER, Sexually transmitted diseases: extract from the annual report of the Chief Medical Officer of the Department of Health and Social Security for the year 1983. Genitourin. Med., 61, 204-207 (1985).
5. CHUA, K., WIKLUND, F., LENNER, P., ÅNGSTRÖM, T., HALLMANS, G., BERGMAN, F., SAPP, M., SCHILLER, J., WADELL, G., HJERPE, A. and DILLNER, J., A prospective cohort study on the risk to develop cervical intraepithelial neoplasia among healthy subjects with serum antibodies to HPV. in comparison with presence of HPV DNA in cervical smears. Int. J. Cancer, 68, 54-59 (1996).
6. COLEMAN, M.P. ESTÉVE, P., DAMIECKI, P., ARSLAN, A. and RENARD, H., Trends in cancer incidence and mortality. IARC Scientific Publication. 121, 433-454. IARC, Lyon (1993).
7. COWAN, F.M., JOHNSON, A.M., ASHLEY, R., COREY, L. and MINDEL, A., Antibody to herpes simplex virus type 2 as seroloeical marker of sexual lifestyle in populations. Brit. med. J., 309, 1325-1329 (1994).
8. DE GRUIJL, T.D. and 12 OTHERS, Immunoglobulin G responses against human papillomavirus type 16 virus-like particles in a prospective noninter- vention cohort study of women with cervical intraepithelial neoplasia. J. nat. Cancer Inst., 89, 630-638 (1997).
9. DILLNER, J., KALLINGS, I., BRIMMER, C., SIKSTRÖM, B., KOSKELA, P., LEHTINEN, M., SCHILLER, J.T., SAPP, M. and MÅRDH, P.A., Seropositivity to human papillomavirus types 16, 18 or 33 capsids and to Chlamydia trachomatis are markers of sexual behaviour. J. infect. Dis., 173, 1394-1398 (1996).
10. DILLNER, J., KNEKT, P., SCHILLER, J.T. and HAKULINEN, T., Prospective seroepidemiological evidence that human papillomavirus type 16 infection is a risk factor for esophageal squamous cell carcinoma. Brit. med. J., 311, 1346 (1995).
11. DILLNER, J. and 13 OTHERS, Prospective seroepidemiological study of human papillomavirus infection as risk factor for invasive cervical cancer. J. nat. Cancer Inst., 89, 1293-1299 (1997).
12. EVANDER, M., EDLUND, K., GUSTAFSSON, A., JONSSON, M., KARLSSON, R., RYLANDER, E. and WADELL, G., Human papillomavirus infection is transient in young women: a population-based cohort study. J. infect. Dis., 171, 1026-1030 (1995).
13. FORSGREN, M., SKOOG, E., JEANSSON, S., OLOFSSON, S. and GIESECKE, J., Prevalence of antibodies to herpes simplex virus in pregnant women in Stockholm in 1969, 1983 and 1989: implications for STD epidemiology. Int. J. STD AIDS, 5, 113-116 (1994).
14. GIESECKE, J., SCALIA-TOMBA, G.-P., GÕTHBERG, M. and TULL, P., Sexual behaviour related to the spread of STDs - a population-based survey. Int. J. STD AIDS, 3, 255-260 (1992).
15. GOLDMAN, S., GLIMELiUS, B., NILSSON, B. and PÅHLMAN, L., Incidence of anal epidermoid carcinoma in Sweden 1970-1984. Acta Chir. Scand., 155, 191-197 (1989).
16. HEINO, P., EKLUND, C., FREDRIKSSON-SHAHNAZARIAN, V., GOLDMAN, S., SCHILLER, J.T. and DILLNER, J., Association of serum IgG antibodies against human papillomavirus type 16 capsids with anal epidermoid carcinoma. J. nat. Cancer Inst., 87, 437-440 (1995).
17. HILDESHEIM, A., SCHIFFMAN, M.H., GRAVITT, P.E., GLASS, A.G., GREER, C.E., ZHANG, T., SCOTT, D.R., RUSH, B.B., LAWLER, P. and SHERMAN, M.E., Persistence of type-specific human papillomavirus infection among cytologically normal women. J. infect Dis., 169, 235-240 (1994).
18. IARC Human papillomaviruses. IARC Monographs on Assessment of Carcinogenic Risks to Humans. 64, IARC, Lyon (1995).
19. KIRNBAUER, R., HUBBERT, N.L., WHEELER, C.M., BECKER, T.M., LOWY, D.R. and SCHILLER, J.T., A virus-like particle ELISA detects serum antibodies in a majority of women infected with human papillomavirus type 16. J. nat. Cancer Inst., 86, 494-499 (1994).
20. LEHTINEN, M., DILLNER, J., KNEKT, P., LUOSTARINEN, T., AROMAA, A., KIRNBAUER, R., KOSKELA, P., PAAVONEN, J., PETO, R., SCHILLER, J.T. and HAKAMA, M., Serologically diagnosed infection with human papillomavirus type 16 and risk for subsequent development of cervical carcinoma. Brit. med. J., 312, 537-539 (1996).
21. LEHTINEN, T., LUMIO, J., DILLNER, J., HAKAMA, M., KNEKT, P., LEHTINEN, M., TEPPO, L. and LEINIKKI, P., Increased risk of malignant lymphoma indicated by elevated Epstein-Barr virus antibodies - a prospective study. Cancer Causes Control, 4, 187-193 (1993).
22. MELKERT, P.W., HOPMAN, E., VAN DEN BRULE, A.J., RISSE, E.K., VAN DIEST, P.J., BLEKER, O.P., HELMERHORST, T., SCHIPPER, M.E., MEIJEK, C.J. and WALBOOMERS, J.M.M., Prevalence of HPV in cytomorphologically normal cervical smears, as determined by the polymerase chain reaction, is age-dependent. Int. J. Cancer, 53, 919-923 (1993).
23. MERTZ, G.J., SCHMIDT, O., JOURDEN, J.L., GUINAN, M.E., REMINGTON, M.L., FAHNLANDER, A., WINTER, C., HOLMES, K.K. and COREY, L., Frequency of acquisition of first episode genital infection with herpes simplex virus from symptomatic and asymptomatic source contacts. Sex. Transm. Dis., 12, 33-39 (1985).
24. NONNENMACHER, B., HUBBERT, N.L., KIRNBAUER, R., SHAH, K.V., MUÑOZ, N., BOSCH, F.X., DE SANJOSÉ. S., VISCIDI, R., LOWY, D.R. and SCHILLER, J.T., Serologic response to human papillomavirus type 16 virus-like particles in HPV 16 DNA-positive invasive cervical cancer and cervical intraepithelial neoplasia grade III patients and controls from Colombia and Spain. J. infect. Dis., 172, 19-24 (1995).
25. OLSEN, A.O., DILLNER, J., GJOEN, K. and MAGNUS, P., Seropositivity against HPV 16 capsids: a better marker of past sexual behaviour than presence of HPV DNA. Genitourin Med., 73, 131-135 (1997).
26. PERSSON, K., MANSSON, A., JONSSON, E. and NORDENFELT, E., Decline of herpes simplex virus type 2 and Chlamydia trachomatis infections from 1970 to 1993 indicated by a similar change in antibody pattern. Scand. J. Infect. Dis., 27, 195-199 (1995).
27. RIPA, T., Epidemiologi. In: E. Sandström (ed.), Sexuellt överförhara sjukdomar-STD, pp. 105-115. Studentlitteratur Publishing, Lund (1994).
28. SCHIFFMAN, M.H., Epidemiology of cervical human papillomavirus infections. Curr. Topics Microbiol. Immunol., 186, 55-81 (1994).
29. SCHIFFMAN, M.H., Epidemiology of human papillomaviruses. Dermatol. Clin., 13, 561-574 (1995).
30. SCHIFFMAN, M.H., BAUER, H.M., HOOVER, R.N., GLASS, A.G., CADELL, D.M., RUSH, B.B., SCOTT, P.R., SHERMAN, M.E., KURMAN, R.J., WACHOLDER, S., STANTON, C.K. and MANOS, M.M., Epidemiological evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J. nat. Cancer Inst., 85, 958-964 (1993).
31. STATISTISKA CENTRALBYRÅN, SVERIGES OFFICIELLA STATISTIK: befolkningsförändringar. del 3. (Official statistics of Sweden. Population changes, part 3). (1974 and 1989).
32. WANG, Z., KONYA. J., ÅVALL-LUNDQUIST, E., SAPP, M., DILLNER, J. and DILLNER, L., Human papillomavirus antibody responses among patients with incident cervical carcinoma. J. med. Virol., 52, 436-440 (1997).
33. WIDEROFF, L. and 15 OTHERS. Epidemiologic determinants of seroreactivity to human papillomavirus (HPV) type 16 virus-like particles in cervical HPV-16 DNA-positive and negative women. J. infect. Dis., 174, 937-943 (1996).
34. WIDEROFF, L., SCHIFFMAN, M.H., NONNENMACHER, B., HUBBERT, N.L., KIRNBAUER, R., GREER, C.E., LOWY, D., LÖRINCZ, A.T., MANOS, M.M., GLASS, A.G. and SCHILLER, J.T., Evaluation of seroreactivity to human papillomavirus type 16 virus-like particles in an incident case-control study of cervical neoplasia. J. infect. Dis., 172, 1425-1430 (1995).
35. WIKSTRÖM, A., VAN DOORNUM, G.J.J., KIRNBAUER, R., QUINT, W.G.V. and DILLNER, J., A prospective study on the development of antibodies against human papillomavirus type 6 among patients with condyloma acuminata or new asymptomatic infection. J. med. Virol., 46, 368-374 (1995a).
36. WIKSTRÖM, A., VAN DOORNUM, G.J.J., QUINT, W.G.V., SCHILLER, J.T. and DILLNER, J., Identification of human papillomavirus seroconversions. J. gen. Virol., 76, 529-539 (1995b).